Schistosomiasis, also known as bilharzia or “snail fever”, is a parasitic disease carried by fresh water snails infected with one of the five varieties of the parasite Schistosoma. Found predominantly in tropical and sub-tropical climates, schistosomiasis infects 240 million people in as many as 78 countries, with a vast majority of the burden occuring in Africa. Schistosomiasis ranks second only to malaria as the most common parasitic disease.
Schistosomiasis is transmitted by contact with contaminated fresh water (lakes and ponds, rivers, dams) inhabited by snails carrying the parasite. Swimming, bathing, fishing and even domestic chores such as laundry and herding livestock can put people at risk of contracting the disease. Larvae emerge from the snails and swim in the water until they come into contact with an individual and penetrate the skin. Once inside the body, the larvae develop into male and female worms which pair up and live together in the blood vessels for years. Female worms release thousands of eggs which are passed out of the body in the urine and feces. If people urinate or defecate in bodies of freshwater, the eggs migrate to snails where they eventually hatch and begin the cycle again.
Some Schistosoma eggs, however, remain trapped in the body and migrate to specific organs (depending on the type of parasite) where they can inflict major damage. Urinary schistosomiasis causes scarring and tearing of the bladder and kidneys, and can lead to bladder cancer. Intestinal schistosomiasis develops slowly, causing abdominal bleeding; enlargement of the liver, lungs and spleen; and damage to the intestines. A major indicator of the disease is blood in the urine and/or feces.
- Contact with freshwater sources where infected snails carrying the disease live
- Prevalent in as many as 78 countries with over half of all documented cases residing in Africa
- Children under age 14
- Individuals with labor or domestic chores centered around freshwater areas
- Symptoms for the disease vary depending on the type of worm involved and the location of the parasite inside the body, and can include initial itching and rash at infection site (“swimmer’s itch”)
- Frequent, painful or bloody urine
- Abdominal pain and bloody diarrhea
- Fever, chills and muscle aches
- Inflammation and scarring of the bladder
- Lymph node enlargement
- Enlargement of the liver or spleen
- Secondary blood disorders in cases of colon damage
- If infection persists, bladder cancer may eventually develop in some cases
- Children with repeated infection can develop anemia, malnutrition and learning disabilities
- Parasites penetrate the skin during contact with freshwater containing contaminated snails. The larvae migrate to the blood vessels where they mate and produce eggs. Some eggs travel to the bladder or intestines and are passed into the urine or stool. Others remain trapped in the body and cause damage to internal organs.
- Education campaigns about risks of getting infected by bathing in fresh water lakes and ponds
- Praziquantel is the primary form of treatment
- A single dose of praziquantel has been shown to reduce the severity of symptoms in cases of subsequent re-infection
- 250 million tablets are donated by Merck KGaA for as long as there is need
- Praziquantel is also available for purchase for 8¢ per tablet
- Baylor College of Medicine and the Texas Children’s Hospital’s Center for Vaccine Development are working to advance research and development of a safe and efficacious vaccine to prevent schistosomiasis
- 240 million people worldwide
- A majority of the burden occurs in Africa
- Schistosomiasis is the most deadly NTD, killing more than 200,000 people each year in Africa
- Twenty million schistosomiasis sufferers develop severe and sometimes disfiguring disabilities from complications from the disease, including kidney disease, liver disease and bladder cancer
- Children with chronic disease can suffer from anemia and malnutrition, which can contribute to lost days at school and pervasive learning disabilities
Recent efforts have focused on targeted distribution of Praziquantel in specific areas thought to be disease-endemic. Schistosomiasis outbreaks can be identified by mapping the rates of blood in the urine of school-age children. If the rates are high, the drug is distributed to the entire community at risk. Annual dosing of Praziquantel is sometimes recommended for areas at high risk for re-infection with the disease, and has also been used to help reduce the severity of symptoms in chronic sufferers. Chronic disease contributes to major organ damage, so reducing the severity of symptoms is critical to the management of schistosomiasis.